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In May 2014, six patients presented in Germany with 
a Sarcocystis-associated febrile myositis syndrome 
after returning from Tioman Island, Malaysia. During 
two earlier waves of infections, in 2011 and 2012, 
about 100 travellers returning to various European 
countries from the island were affected. While the 
first two waves were associated with travel to Tioman 
Island mostly during the summer months, this current 
series of infections is associated with travel in early 
spring, possibly indicating an upcoming new epidemic.
Here we report the clinical and laboratory findings 
of a new, third wave of Sarcocystis-associated febrile 
myositis syndrome in travellers returning to Germany 
from Tioman Island, Malaysia, in spring 2014. 
Case series
Six previously healthy German patients, aged 15–44 
years were seen in early May 2014 in travel clinics in 
Tübingen, Saarbrücken and Munich, with a febrile 
myositis syndrome after travel. The patients (three 
female, three male) complained of current or very 
recent episodes of fever of up to 40 °C, headache and 
myalgia.  All had returned at the end of March to the 
end of April from Tioman Island, Malaysia. Laboratory 
investigations revealed eosinophilia in all but one and 
elevated muscle enzyme levels in half of the patients 
(Table). There were no clinically relevant electrocardio-
gram abnormalities but mild splenomegaly was seen 
in some. Serological tests for trichinellosis, toxoplas-
mosis and dengue virus infection were negative in all 
patients. Tests for chikungunya virus antibodies were 
not carried out for one patient, but negative in all oth-
ers. All patients had stayed in the north-west of Tioman 
Island and developed symptoms 1–18 days (mean: 10) 
after leaving the island. Their travel history, including 
locality of lodging on the island, estimated incubation 
time (a few days to three weeks), clinical picture and 
laboratory results were consistent with the Sarcocystis-
associated febrile myositis syndrome seen in travellers 
returning to various European countries from Tioman 
Island in 2011 and 2012 [1-4]. No such series of infec-
tions were seen in 2013.
Patients 1–3
In three patients who sought medical attention 1–6 days 
after first onset of fever, headache and slight myalgia 
(i.e. in the early, rather non-specific phase of clinical 
disease) and who had no elevated creatine kinase (CK) 
levels, therapy with trimethoprim/sulfamethoxazole 
(cotrimoxazole) (2 × 960 mg/day) [4] was started within 
a few days. All three improved clinically but developed 
higher eosinophilia after 7–20 days, yet there was no 
elevation of CK level. 
Patients 4–5
A couple presented in a later phase of the disease. One 
patient was currently asymptomatic with moderate CK 
elevation 23 days after a previous short-lived febrile 
episode. The other had fever and severe myalgia plus 
high eosinophilia and CK elevation 28 days after onset 
of a short-lived episode with high fever, headaches and 
night sweats. Both showed a further increase of eosin-
ophil counts (maximum count of 500/µl and 5,260/
µl, respectively) after the start of cotrimoxazole treat-
ment. The previously symptom-free patient developed 
moderate myalgia together with increasing CK levels 
thereafter; the other had to be started on high-dose 
steroids four days later (prednisolone starting dose 
100 mg/day) because of intensifying severe myalgia. 
Patient 6
The patient with the longest interval (43 days) since 
onset of first symptoms (fever, headache, myalgia) 
was treated with steroids (prednisolone starting dose 
40 mg/day). 
Administration of steroids resulted in rapid clini-
cal improvement in both patients (Patients 5 and 6), 
similar to observations during the first two waves of 
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Sarcocystis-associated febrile myositis syndrome in 
travellers returning from Tioman Island in 2011 and 
2012 [3,4]. 
In the current cluster, no muscle biopsies were taken 
and the presumptive diagnosis was based on the travel 
history, symptoms and blood test results of increas-
ing eosinophil count and CK level and the exclusion of 
other infectious causes. 
Background
Sarcocystosis is a cosmopolitan zoonotic disease that 
is caused by intracellular apicomplexan/coccidian 
parasites of the genus Sarcocystis, with more than 120 
recognised species [5]. These protozoal parasites are 
maintained in a two-host life cycle involving a carnivore 
predator final host and its ‘prey’ as intermediate host, 
such as snake–rodent or human–cattle relationships, 
for example. In the intermediate host, invasive muscu-
lar sarcocystosis develops after infective Sarcocystis 
oocysts shed in faeces of an infected final host are 
ingested. Sporozoites are released from the oocysts, 
which invade muscular tissue of the intermediate host 
after several cycles of replication. In the myocytes, 
tube- or sac-like sarcocysts are eventually formed, 
which contain numerous single-celled bradyzoites. 
When the intermediate host falls prey to a carnivore or 
omnivore, the bradyzoites can complete their life cycle 
sexually in the intestine of the final host. Humans are 
final hosts for two Sarcocystis species, S. hominis and 
S. suihominis, which cause non-invasive self-limiting 
diarrhoeal symptoms [5]. However, humans can serve 
as accidental intermediate hosts after incidental inges-
tion of food faecally contaminated with oocysts for 
a presumed number of several Sarcocystis species, 
among them S. nesbitti, [6,7] and develop  the inva-
sive muscular form.  Invasive muscular sarcocystosis 
causes fever and myalgia, but not diarrhoea, in con-
trast to the intestinal form.
Table
Characteristics of patients returning from Tioman Island, Malaysia, with Sarcocystis-associated febrile myositis syndrome, 
May 2014 (n=6)
Characteristic
Patient number
Norm
1 2 3 4 5 6
Sex M F M F M F –
Days from departure from 
Tioman Island, Malaysia, until 
symptom onset 
9 12 7 18 13 1 –
Myalgia (yes/no) yes yes yes yes yes yes –
Maximum pain (score 0=none 
to 10=maximum) 2 4 4 6 9.5 8 –
Arthralgia (yes/no) yes yes yes no no yes –
Headache (yes/no) yes yes yes yes yes yes –
Neck pain (yes/no) no yes yes no yes yes –
Body temperature (°C) No data 38 38 38 40 40 –
Laboratory tests 
Creatine kinase (U/L) 138 80 133 159 207 450 <170 males;  <145 females
Creatine kinase MB fraction 
(U/L) 21 15 14 22 35 9
<25 or <6% of 
total creatine 
kinase
Cardiac troponin (troponin I/ 
troponin T, µg/L) <0.014 <0.014 <0.014 Negative Negative Not done <0.4
Lactate dehydrogenase (U/L) 326 342 383 201 324 307 <240
Aspartate amino transferase 
(U/L) 49 56 46 18 39 23
<50 males; 
<35 females
Eosinophil count per µl 430 620 260 170 4,490 1,150 <350
Eosinophils (%) 9 8 4 8 41 12 <7
Spleen length (cm) 13.2 9.2 13.0 No data 12.1 12.5 <11 
Treatment Co-trimoxazolea
Co-
trimoxazolea
Co-
trimoxazolea
Co-
trimoxazolea
Cotrimoxazolea 
plus 
prednisolone
Prednisolone –
Days from symptom onset to 
start of treatment 6 3 8 23 28 43 –
F: female; M: male.
a Trimethoprim/sulfamethoxazole.
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Already in 1991, sarcocystosis was regarded as a possi-
ble emerging food-borne zoonosis in Malaysia, as high 
human seroprevalence [8] and high positive autopsy 
rates [9] were found. In 1993, the first cluster of patients 
with symptomatic muscular sarcocystosis was seen in 
United States service personnel in rural Malaysia [10]. 
In 2011 and 2012, in a two-wave outbreak, the larg-
est series of symptomatic muscular sarcocystosis in 
humans worldwide was noted in travellers returning to 
Europe from Tioman Island, Malaysia [1-4]. The course 
of disease was typically biphasic, with a prodromal 
stage of one week characterised by fever, myalgia 
and headache, followed by a two-week asymptomatic 
period and later by a long-lasting feverish episode 
with severe myalgia with eosinophilia and CK level 
elevation [4]. An environmental survey for Sarcocystis 
oocysts conducted in November 2011 on Tioman Island 
could not detect the source of infection [11]. 
Definitive diagnosis is achieved after muscle biopsy 
with histological demonstration of typical sarcocysts 
or by molecular methods [3,6]. However, despite severe 
myalgia, parasite density in the muscle is apparently 
low and sarcocysts have thus been detected in a few 
patients only [3,4,6,10]. |
Conclusions
This cluster of travellers with a febrile myositis syn-
drome returning from Tioman Island indicates the 
beginning of a third wave of a presumably Sarcocystis-
associated invasive illness. In the first two waves, in 
2011 and 2012, patients acquired the disease mainly in 
the summer months (July to October) [1-4]. In contrast, 
symptom onset in patients of this current new clus-
ter took place in spring, possibly indicating a larger 
upcoming epidemic in returning travellers in the sum-
mer months of this year. 
The source of the infection on the island has not been 
determined so far, but is obviously persisting or re-
emerging. The nearly simultaneous outbreak of inva-
sive sarcocystosis among Malaysian students and 
teachers on a different Malaysian island, Pangkor [6], 
is intriguing. The snake-associated S. nesbitti [6,7,12] 
was molecularly determined to be the causative agent 
on Pangkor. The quest for the Sarcocystis species 
involved, the source of infection and the animal reser-
voir on Tioman Island is currently ongoing. It remains 
to be determined whether environmental factors, such 
as climate change or increasing reptile populations 
(i.e. possible final hosts) [13], play a role in this disease 
(re-) emergence. 
Physicians should be aware of this unusual re-emerg-
ing outbreak and pre-travel advice should be given 
regarding individual prevention measures, such as 
the consumption of cooked food, well-peeled fruit and 
pre-packed or boiled/filtered water only. Treatment 
with cotrimoxazole may be a therapeutic approach in 
the early phase of disease to prevent muscle invasion, 
whereas steroids seem effective to treat severe myal-
gia/myositis in the later phase.
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